Adverse effects and complications of treatment with beta-adrenergic agonist drugs. Committee on drugs, the American Academy of Allergy and Immunology.
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D000402:Airway Obstruction / Q000139:chemically induced; D001249:Asthma / Q000188:drug therapy / Q000401:mortality; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002302:Cardiac Output / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D003327:Coronary Disease / Q000139:chemically induced; D004837:Epinephrine / Q000009:adverse effects; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D013726:Terbutaline / Q000009:adverse effects
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D013726:Terbutaline; D004837:Epinephrine